# Cardiovascular System in Obesity: Effect of Treatment

> **NCT00000506** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Heart Diseases
- Obesity
- Vascular Diseases

## Interventions

- **DRUG:** fenfluramine
- **DRUG:** phentermine

## Key facts

- **NCT ID:** NCT00000506
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1983-05
- **Primary completion:** —
- **Final completion:** 1988-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000506, "Cardiovascular System in Obesity: Effect of Treatment". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00000506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*